CN1117733C - 核苷酸还原酶抑制剂3-ap和3amp的合成方法 - Google Patents
核苷酸还原酶抑制剂3-ap和3amp的合成方法 Download PDFInfo
- Publication number
- CN1117733C CN1117733C CN98805147A CN98805147A CN1117733C CN 1117733 C CN1117733 C CN 1117733C CN 98805147 A CN98805147 A CN 98805147A CN 98805147 A CN98805147 A CN 98805147A CN 1117733 C CN1117733 C CN 1117733C
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- formula
- aldehyde
- following formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (21)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/856,559 | 1997-05-15 | ||
US08/856,559 US5869676A (en) | 1997-05-15 | 1997-05-15 | Process for the synthesis of ribonucleotide reductase inhibitors 3-AP and 3-AMP |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1256688A CN1256688A (zh) | 2000-06-14 |
CN1117733C true CN1117733C (zh) | 2003-08-13 |
Family
ID=25323946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98805147A Expired - Lifetime CN1117733C (zh) | 1997-05-15 | 1998-05-14 | 核苷酸还原酶抑制剂3-ap和3amp的合成方法 |
Country Status (11)
Country | Link |
---|---|
US (1) | US5869676A (zh) |
EP (1) | EP0984932A4 (zh) |
JP (1) | JP2001526665A (zh) |
KR (1) | KR20010012616A (zh) |
CN (1) | CN1117733C (zh) |
AU (1) | AU728165B2 (zh) |
BR (1) | BR9808810A (zh) |
CA (1) | CA2289970A1 (zh) |
HK (1) | HK1025567A1 (zh) |
RU (1) | RU2198875C2 (zh) |
WO (1) | WO1998051670A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6951875B2 (en) | 2001-10-29 | 2005-10-04 | Hoffmann-La Roche Inc. | Conjugated aromatic compounds with a pyridine substituent |
CN1889943A (zh) * | 2003-12-08 | 2007-01-03 | 美国亚利桑那大学董事会 | 协同抗癌组合物 |
US8029815B2 (en) * | 2004-04-28 | 2011-10-04 | Elford Howard L | Methods for treating or preventing restenosis and other vascular proliferative disorders |
EP2030615A3 (en) * | 2007-08-13 | 2009-12-02 | ELFORD, Howard L. | Ribonucleotide reductase inhibitors for use in the treatment or prevention of neuroinflammatory or autoimmune diseases |
MD3995C2 (ro) * | 2009-05-11 | 2010-07-31 | Государственный Университет Молд0 | Utilizare a di(µ-Ofenoxi)-di{[2-(4-aminobenzensulfamido)-5-etil-1,3,4-tiadiazol]-3,5-dibromosalicilidentiosemicarbazonato(-1)-cupru} în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamar |
MD4126C1 (ro) * | 2010-11-15 | 2012-04-30 | Государственный Университет Молд0 | N,N'-[4,4'-(perfluoro-1,4-fenilendioxi)-bis(4,1-fenilen)]-bis[2-(piridin-2-ilmetilen)hidrazincarbotioamidă] şi utilizarea ei în calitate de inhibitor al proliferării celulelor LNCaP ale cancerului prostatei |
MD4132C1 (ro) * | 2010-12-13 | 2012-05-31 | Государственный Университет Молд0 | Di(µ-S)-bis{cloro-[fenil(piridin-2-il)metanon-tiosemicarbazonato(1-)]cupru} care manifestă proprietatea de inhibare a proliferării celulelor T-47D ale cancerului mamar |
CN102627593A (zh) * | 2012-02-23 | 2012-08-08 | 河南师范大学 | 具有抗癌活性的1,4-二羟基-2-甲酰基-9,10蒽醌缩氨硫脲新化合物及制备方法 |
US20140271812A1 (en) | 2013-03-14 | 2014-09-18 | Panacea Pharmaceuticals | Treatment for chemotherapy-induced cognitive impairment |
US20140287021A1 (en) | 2013-03-21 | 2014-09-25 | Panacea Pharmaceuticals | Treatment of chemotherapy-induced peripheral neuropathy |
CN104945313A (zh) * | 2015-06-19 | 2015-09-30 | 洪帅金 | 一种2-甲基-3-溴吡啶的制备方法 |
CN105198802A (zh) * | 2015-11-03 | 2015-12-30 | 江苏梦得电镀化学品有限公司 | 一种2-甲基-3-溴吡啶的制备方法 |
CN112592330A (zh) * | 2020-12-14 | 2021-04-02 | 陕西师范大学 | 一种2-醛基硫色酮类化合物的合成方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW299317B (zh) * | 1993-03-12 | 1997-03-01 | Chemie Linz Gmbh |
-
1997
- 1997-05-15 US US08/856,559 patent/US5869676A/en not_active Expired - Lifetime
-
1998
- 1998-05-14 CA CA002289970A patent/CA2289970A1/en not_active Abandoned
- 1998-05-14 AU AU75714/98A patent/AU728165B2/en not_active Ceased
- 1998-05-14 EP EP98923414A patent/EP0984932A4/en not_active Withdrawn
- 1998-05-14 RU RU99126808/04A patent/RU2198875C2/ru not_active IP Right Cessation
- 1998-05-14 WO PCT/US1998/009803 patent/WO1998051670A1/en not_active Application Discontinuation
- 1998-05-14 JP JP54951498A patent/JP2001526665A/ja not_active Ceased
- 1998-05-14 BR BR9808810-6A patent/BR9808810A/pt not_active IP Right Cessation
- 1998-05-14 CN CN98805147A patent/CN1117733C/zh not_active Expired - Lifetime
- 1998-05-14 KR KR1019997010575A patent/KR20010012616A/ko not_active Application Discontinuation
-
2000
- 2000-07-29 HK HK00104763A patent/HK1025567A1/xx not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
JOURNAL OF MEDICINAL CHEMISTRY VOL.35.NO.20 1992-01-01 LIR.M.CSYNTHESIS AND ANTI-TUMORACTIVITY OF AMINO DERIVATIVES OF PYRIDINE CARBOXALDEHYDE THIOSEMICAR * |
Also Published As
Publication number | Publication date |
---|---|
EP0984932A1 (en) | 2000-03-15 |
JP2001526665A (ja) | 2001-12-18 |
CA2289970A1 (en) | 1998-11-19 |
RU2198875C2 (ru) | 2003-02-20 |
KR20010012616A (ko) | 2001-02-26 |
WO1998051670A1 (en) | 1998-11-19 |
AU7571498A (en) | 1998-12-08 |
CN1256688A (zh) | 2000-06-14 |
US5869676A (en) | 1999-02-09 |
AU728165B2 (en) | 2001-01-04 |
EP0984932A4 (en) | 2001-04-04 |
HK1025567A1 (en) | 2000-11-17 |
BR9808810A (pt) | 2000-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107148417B (zh) | 苯并氮杂*磺酰胺化合物 | |
JP7279057B6 (ja) | Pd1/pd-l1活性化の阻害剤としてのピリミジン誘導体 | |
CN1117733C (zh) | 核苷酸还原酶抑制剂3-ap和3amp的合成方法 | |
CN105566290B (zh) | 异吲哚啉衍生物、其中间体、制备方法、药物组合物及应用 | |
CA2380389A1 (en) | Biarylurea derivatives | |
EA024681B1 (ru) | Имидазопиридины в качестве противовирусных средств против респираторно-синцитиального вируса | |
JP2015531776A (ja) | 3−(5−アミノ−2−メチル−4−オキソキナゾリン−3(4h)−イル)ピペリジン−2,6−ジオンのアイソトポログ及びその製造方法 | |
CN111961034A (zh) | 用作ret激酶抑制剂的化合物及其应用 | |
CA2690337A1 (fr) | Derives de 7-alkynyl-1,8-naphthyridones, leur preparation et leur application en therapeutique | |
CN114105978A (zh) | 一种氧化吲哚类化合物及其制备方法和应用 | |
JP2007230963A (ja) | 2,4−ジ置換ピリジンの製造法 | |
CN103193763B (zh) | 一种来那度胺的制备方法 | |
KR20190111089A (ko) | Jak 효소 억제제 및 이의 제조 방법과 용도 | |
CN110272417B (zh) | 2-甲基-1,8-萘啶类化合物及其制备方法与应用 | |
CN110511197B (zh) | 一种n-呋喃酮基芳基磺酰腙类化合物及其合成方法和应用 | |
CN103980177B (zh) | 一种烯二炔化合物及其制备方法和应用 | |
CN115181051B (zh) | 一种含吲哚骨架的亚砜化合物的制备方法 | |
WO2001005750A1 (fr) | COMPOSES DE p-TERPHENYLE A CHAINES LATERALES D'ACYLOXYMETHOXYCARBONYLE | |
CN114213396B (zh) | 一种吲哚-2-酮类化合物及其制备方法与用途 | |
CN113429424B (zh) | 一种[1,2,4]噁二嗪并吲哚啉-3-酮衍生物的制备方法 | |
Błachut et al. | A Suzuki-Miyaura approach to a series of forensically relevant pyridines | |
EP0842924A1 (en) | Pyridine intermediates, useful in the synthesis of beta-adrenergic receptor agonists | |
Muchowski | 1-Methylthio-3-lithioisoquinoline. The first simple isoquinoline derivative lithiated at the 3-position | |
Gaikwad et al. | Chemical Methodologies | |
CN113845481A (zh) | 一种4,4-二甲基-4,5-二氢哒嗪-3-酮的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Beijing send medicine technology Co., Ltd. Assignor: Vion Pharmaceuticals Inc. Contract fulfillment period: Validity of patent right Contract record no.: 031000030259 Denomination of invention: Method for synthesizing nucleotide reductase inhibitors 3-AP and 3AMP Granted publication date: 20030813 License type: Exclusive license Record date: 20031027 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENCE; TIME LIMIT OF IMPLEMENTING CONTACT: PATENT VALIDITY Name of requester: BEIJING PAISHENG PHARMACEUTICAL TECHNOLOGY CO., L Effective date: 20031027 |
|
CX01 | Expiry of patent term |
Granted publication date: 20030813 |
|
CX01 | Expiry of patent term |